Paraganglioma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Sergekorjian (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{AAM}} | {{CMG}} {{AE}} {{AAM}} | ||
==Overview== | ==Overview== | ||
<sup>123</sup>I-metaiodobenzylguanidine (MIBG) scintigraphy coupled with CT imaging can be used for diagnosis of | <sup>123</sup>I-metaiodobenzylguanidine (MIBG) scintigraphy coupled with CT imaging can be used for diagnosis of paraganglioma. | ||
==Other Imaging Studies== | ==Other Imaging Studies== | ||
Other imaging studies may include: | Other imaging studies may include: | ||
Revision as of 15:35, 23 September 2015
|
Paraganglioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Paraganglioma other imaging findings On the Web |
|
American Roentgen Ray Society Images of Paraganglioma other imaging findings |
|
Risk calculators and risk factors for Paraganglioma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
123I-metaiodobenzylguanidine (MIBG) scintigraphy coupled with CT imaging can be used for diagnosis of paraganglioma.
Other Imaging Studies
Other imaging studies may include:
- 123I-metaiodobenzylguanidine (MIBG) scintigraphy
- 111In-octreotide scintigraphy
- 18F-fluorodeoxyglucose positron emission tomography